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INTRODUCTION
Preeclampsia is a disorder of pregnancy marked by
hypertension and proteinuria after 20 weeks of gesta-
tion. Preeclampsia is still one of the major causes for
maternal morbidity and mortality. The general preva-
lence of preeclampsia is 4.4 - 17.5%, with average of
4.6%.1 In Indonesia, the incidence of preeclampsia is
3 - 10%, and contributes to 39.5% of maternal mor-
tality in 2001, and 55.56% in 2002.2
Transplantation of organs were related with major
histocompatibility complex (MHC), such as human
leucocyte antigens (HLA). In pregnancy, there is in-
vasive interaction between decidua and cytotropho-
blast. The Human Leucocyte Antigens-G (HLA-G)
have role in semiallogenic immune tolerance of the
fetus that adequate HLA-G expression of the tro-
phoblast will prevent such maternal immune response.
The decidua contains Large Granular Lymphocytes
(LGLs), such as Natural Killer Cell (NK cell), which
will destroy any cell with inadequate HLA-G expres-
sion. HLA-G is monomorphic class Ib non-classic
HLA molecule, which is able to inhibit the activity
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Abstrak
Tujuan: Untuk menganalisis ekspresi protein MHC Klas Ib Qa-
2 (homolog HLA-G pada manusia), protein Hsp-70 dan protein
VCAM-1 di trofoblas pada preeklampsia dan hamil normal dengan
menggunakan model disfungsi endotel pada hewan coba Mus Mus-
culus.
Metode: Eksperimental dengan cara membuat mencit bunting ti-
dak mengekspresikan Qa-2 dan menganalisis ekspresi Hsp-70 dan
VCAM-1 pada trofoblasnya baik pada minggu I, II maupun III.
Hasil: Qa-2 negatif terjadi pada dosis 40 ng yaitu pada kebun-
tingan hari ke-5. Ekspresi Hsp-70 dan VCAM-1 pada mencit bun-
ting Qa-2 negatif (preeklampsia) lebih tinggi dibandingkan dengan
ekspresinya pada mencit bunting Qa-2 positif (hamil normal) baik
pada kebuntingan minggu I, II maupun III.
Kesimpulan: Ekspresi HLA-G/Qa-2 yang rendah, protein Hsp-
70 dan VCAM-1 yang tinggi merupakan prediktor untuk terjadinya
preeklampsia (disfungsi endotel).
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of NK cells and the decidual LGL. Thus, HLA-G pos-
sesses the function of protecting trophoblast from the
influence of maternal immune system, or cytotoxic
attack.3 During pregnancy, the trophoblast increase
regulation of HLA-G expression.
An adequate HLA-G expression is needed for tro-
phoblastic invasion into decidua and maternal vascu-
lar system. This invasive trophoblast cells might me-
diate changes that on increase in uterine perfusion is
needed to ensure adequate blood supply during preg-
nancy.
Without proper invasion, the maternal artery re-
modelling did not occur and subsequent decrease of
utero-placental supply will cause placental hypoxia, a
condition which precludes preeclampsia. This is in ac-
cordance with the hypothesis that preeclampsia is
caused by abnormality in utero-placental local im-
mune recognition, between mother and fetus.3
Qa-2 protein, product of Ped gene in mice, is a
MHC class Ib protein related to the glycophosphatidil
inositol (GPI) found on the surface of T cell and pre-
implanted embryo in ice.4 The Qa-2 protein manage
early embryonic development in mice, and its sub-
sequent survival. This protein is expressed on the sur-
face of preimplanted mice embryo from two cell stage
up to blastocyst stage, after which it will be expressed
by inner cell mass and trophoectoderm.
The mice embryo that expresses Qa-2 have faster
cell division, better survival and better birth weight
compared to the control. On the contrary, embryo that
does not express Qa-2, shows miscarriage, having an
embryonal/fetal death, premature birth and low birth
weight.5
Heat shock protein (Hsp) is known as protecting
cells against cytotoxic disturbance. Hsp is a group of
inducible protein, in which, some are expressed con-
stantly, and increased as a respond to stress, while
others are expressed later. The permanently expressed
proteins have role as a messenger for other cell pro-
duction and binds polypeptides that prevent premature
folding, and as a translocation factor for proteins into
the organels. Induced stress proteins can protect cells
from stress-induced damage by preventing protein de-
naturation and or by fixing the damage.
Hsp overexpression has an important role in cell
protection during physiologic stress against apoptosis.
In preeclampsia, it is possible that the placenta system
experience an overwhelming stress, and this may be
the reason for increased in Hsp production.
Xu (et al) wrote that Hsp may play a role in the
repair of denaturated protein caused by oxidative
stress and in the folding of new polypeptide chain,
thus the Hsp-70 is important for keeping homeostasis
during oxidative stress. Oxidant free radical may trig-
ger the increase of Hsp-70 in order to protect cells
from oxidative stress and apoptosis in preeclampsia.
It is concluded that the increase of Hsp-70 is related
to the placenta of preeclamptic women.
Preeclampsia was related with the increase of sol-
uble VCAM, e-selectin, and ICAM-1 in the maternal
serum. This increase may constitute a beginning. The
increase in soluble cell adhesion molecule reflects the
increase of various cell adhesion molecules in endo-
thelial cell, and explains the leucocyte activation in
preeclampsia.
Research using human trophoblastic tissue of first
trimester is not common, as it may cause abortion and
is not ethical. Researchers then use laboratory animal
to study preeclampsia at early gestation to assess any
endothelial damage or dysfunction in the placental
vasculature.7 Even though there were dissimilarity be-
tween preeclampsia in la-boratory animal and in hu-
man, we can use laboratory animal as comparison.
The objective of this research is to assess Qa-2 (ho-
molog to human HLA-G), Hsp-70 and VCAM-1 pro-
tein expression in trophoblast of preeclamptic and
control using laboratory animal Mus Musculus with
endothelial dysfunction model.
METHOD
This study was performed in the animal pen labora-
tory of Airlangga University Veterinary Medicine
Faculty to obtain pregnant mice, anti-Qa-2 treatment
and maintain their pregnancy to 1st, 2nd and 3rd week
of gestation. Immunofluorescence and immunohisto-
chemocal studies were performed in Pathology Labo-
ratory of Airlangga University, Faculty of Veterinary
Medicine. This study was conducted from August to
September 2009. The choice to use Mus Musculus
mice was based on genetic similarity with human and
adaptability in laboratory environment.8 The number
of sample was 120 (60 mice each for the first and
second stage) based on the replication formula of
Steel and Torrie.9 The first stage in this study is to
mate the mice, while the second stage is to administer
of anti Qa-2.
First Stage Research
Mice impregnantion
We synchronized the mice estrus by injecting 5 IU
Pregnant More Serum Gonadotrophin (PMSG) hor-
mone, followed by 5 IU Human Chorionic Gonadot-
rophin (hCG) injection 48 hours later, to 3 - 4 months
old female mice. Female mice are then mated using
monomating technique. They were put alternately in
a cage that contained one 7 months old male mice
weighed 60 grams. Diagnosis of pregnancy was es-
tablished 17 hours after mating with the presence of
copulatory plug.
Treatment of anti Qa-2
After diagnosis of pregnancy, they were separated
into 6 groups (each contains 10 mice). Group I (con-
trol) did not receive anti Qa-2 treatment. Group II
received 10 ng of anti Qa-2 on day 1 and Qa-2 was
assessed on day 2 of pregnancy. Group III received
10 ng of anti Qa-2 on day 1 and 2 and Qa-2 was
assessed on day 3 of pregnancy. Group IV received
10 ng of anti Qa-2 from day 1 to 3 and Qa-2 was
assessed on day 4 of pregnancy. Group V received
10 ng of anti Qa-2 from day 1 to 4 and Qa-2 was
assessed on day 5 of pregnancy. Group VI received
10 ng of anti Qa-2 from day 1 to 5 and Qa-2 was
assessed on day 6 of pregnancy.
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Qa-2 analysis using immunoflourescence 
Pregnant mice were dissected along the uterus and
cleansed using PBS. Uterus were labeled using anti
mouse Qa-2 FITC for 30 min in CO2 incubator. They
were then inspected for Qa-2 signal (green) using
fluorescence microscope.
Second Stage Research
Hsp-70 and VCAM-1 expressions of trophoblast cells
were assessed on day 6, 12 and 18 using immunohis-
tochemical methods in both anti-Qa 2 treatment group
and control. Pregnant mice was first received anti-Qa
2.
RESULTS
The First Stage
There was no Qa-2 expressions after total 40ng anti-
Qa 2 treatment. Qa-2 was expressed by green color
under inverted fluorescence microscope.
In Figure 1, the whole trophoblasts looked green,
which shows the presence of Qa-2. Figure 2 showed
a gleam fluorescence indicating the lack of Qa-2.
The Second Stage
Control group (positive Qa-2 expression)
This group consist of 30 pregnant mice. Ten mice
were dissected each on day 6, 12 and 18 of pregnancy
respectively. We assessed Hsp-70 and VCAM-1 in
trophoblast cells using immunohistochemistry method.
Treatment group (negative Qa-2 expresssion)
This group consist of 30 pregnant mice received 40
ng anti-Qa-2. Ten mice were dissected each on day
6, 12 and 18 of pregnancy respectively. We assessed
Hsp-70 and VCAM-1 in trophoblast cells using im-
munohistochemistry method.
Hsp-70 expression in treatment and control group
? Day 6 pregnant mice
Hsp-70 expression was being assessed in treatment
and control group mice using light microscope
(400x). Hsp-70 was significantly more expressed
in control group (31.8 ± 6.92% of field of view)
compared with those of treatment group (25.00 ±
4.00% of field of view) with p=0.02 (95% confi-
dence interval).
Figure 2. Negative Qa-2 as a control.
Figure 3. Hsp-70 expression in Qa-2 positive pregnant mice.
Figure 4. Hsp-70 expression in Qa-2 negative pregnant mice.
Figure 1. Positive Qa-2 as a control.
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Table 1 shows average distribution of trophoblastic
Hsp-70 expression.
Table 1. The distribution of Hsp-70 expression in control and
treatment group on day 6.
Group N average distribution of Hsp-70
(% of field of view)
Treatment 10 25.00 ± 4.00
Control 10 31.8  ± 6.92
*t-test
? Day 12 pregnant mice
Hsp-70 was significantly more expressed in control
group (2.04 ± 0.26% of field of view) compared
with those of treatment group (1.48 ± 0.16% of
field of view) with p≤0.01 (95% confidence inter-
val).
? Day 18 pregnant mice
Hsp-70 was significantly more expressed in control
group (2.03 ± 0.08% of field of view) compared
with those of treatment group (0.14 ± 0.01% of
field of view) with p=0.049 (95% confidence in-
terval).
VCAM-1 Expression in Treatment and Control
Group
? Day 6 pregnant mice
VCAM-1 expression was assessed in treatment and
control group mice using light microscope (400x).
VCAM-1 was significantly more expressed in con-
trol group (31.80 ± 6.92% of field of view) com-
pared with those of treatment group (25.00 ± 4.00%
of field of view) with p=<0.01 (95% confidence
interval).
Table 2 shows average distribution of trophoblastic
VCAM-1 expression.
Table 2. The average distribution of VCAM-1 expression in
control and treatment group on day 6.
Group N average distribution of VCAM-1
expression (% of field of view)
Treatment 10 25.00 ± 4.00
Control 10 31.80 ± 6.92
? Mice on their second week pregnancy (day 12 of
pregnancy)
The average distribution of VCAM-1 expression in
the negative Qa-2 mice was higher (16.60 ± 4.22%
of field of view), compared to the positive Qa-2
mice (1.40 ± 0.69% of field of view).
Analysis of VCAM-1 expression variables was per-
formed using a normal distribution test (Kolmo-
gorov-Smirnoff) on positive Qa-2 mice and
? Day 18 pregnant mice
VCAM-1 was significantly more expressed in con-
trol group (97.70 ± 3.62% of field of view) com-
pared with those of treatment group (1.40 ± 0.51%
of field of view) with p=<0.01 (95% confidence
interval).
DISCUSSION
This is an experimental study using Mus musculus to
assess the role of class Ib MHC (HLA-G/Qa-2), Hsp-
70 and VCAM in preeclampsia. Human experiments
can only be performed by studying trophoblast taken
after birth, while studies on first and second trimesters
were hindered by ethical problems. Due to invasive
method needed to obtain the trophoblast cells there-
fore, early pregnancy study can only be performed on
animal models.
Mice Qa-2 is Functional Homologue of Human
HLA-G
Both HLA- and Qa-2 are class Ib MHC molecule and
have similarity in structure, non-peptide binding, mem-
brane bound and soluble isoform, expression by pre-im-
planted embryo, similar role with pre-implan-ted em-
bryo growth rate, good fetal survival, and adequate
birthweight. The only difference is their linkage to
membrane; Qa-2 is GPI linked, while HLA-G is not.5
Higher Hsp-70 Protein Expression in control
group
In normal pregnancy, there is an oxidative balance
throughout pregnancy. In pathologic pregnancy, such
Figure 5. VCAM-1 expression in Qa-2 positive pregnant mice.
Figure 6. VCAM-1 expression in Qa-2 negative pregnant mice.
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as preeclampsia, the excessive production of reactive
oxygen species (ROS) can occur on certain parts of
placental development. This might decrease perfusion
function and cause accumulation of placental debris
due to apoptosis.
In this study, there was significant increase in tro-
phoblast tissue Hsp-70 expression on the 1st, 2nd and
3rd week of gestation, on negative Qa-2 pregnant mice
compared to its expression in positive Qa-2 pregnant
mice (control group). This was in accordance with
Padmini (et al) study. Padmini compared Hsp-70 ex-
pression (constitutive HSC-70), and inducible (Hsp-
70) form) with oxidative stress condition in pree-
clampsia compared with those in control. HSC-70 and
placental Hsp-70 concentration was significantly
higher in preeclampsia (p<0,001) compared to control
group. High concentration Hsp-70 in placenta of pree-
clampsia indicated the multiple protection effect to
the cellular stress response.10 Hung (et al) concluded
that the increase of Hsp-70 in placental was a com-
pensatory response toward ischemia, such as oxida-
tive stress in preeclampsia.11
Higher VCAM-1 Protein Expression in Control
Group
Endothelial dysfunction is one of preeclampsia patho-
genesis and is expressed through VCAM-1, apart
from expression of some other endothelial cell mole-
cule. The increase of VCAM-1 expression in future
preeclampsia patients at later gestational age, proved
endothelial cell involvement weeks before clinical
symptom of preeclampsia appear. This may serve as
a parameter to predict preeclamptic risk in preg-
nancy.12
In this study, VCAM-1 was significantly more ex-
pressed in control group compared with those of treat-
ment group day 6, 12 and 18 of pregnancy. The in-
creased of VCAM-1 expression corroborates that en-
dothelial damage occurs in early and worsen as preg-
nancy becomes older.
Austgulen (et al) reported higher VCAM-1 expres-
sion in preeclamptic woman compared with control.
Zhon (et al) reported the human trophoblastic failure
to imitate vascular adhesion phenotype in preeclamp-
sia. The changes of VCAM-1 that happened in the
first trimester may be related to its increase in the
second trimester, and might leads to the development
of preeclampsia in the third trimester.13 John T (et al)
reported higher VCAM-1 expression in placental bed
(endothelium of spiral artery, as well as trophoblastic
cells) in preeclampsia compared with control.14
CONCLUSION
Hsp-70 and VCAM-1 protein expression is higher in
low, or lack of expression of class Ib MHC protein
(HLA-G/Qa-2) of the trophoblast tissue might be
associated with endothelial dysfunction in preeclamp-
sia.
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